Skip to main content

Table 4 Associations between other patient factors and hypertension control

From: Patient-level factors influencing hypertension control in adults in Accra, Ghana

Variable

Controlled BP

  

No

Yes

χ2

p-value

n(%)

n(%)

  

Comorbidity

 No

59(62.11)

36(37.89)

15.2969

< 0.001

 Yes

217(81.89)

48(18.11)

  

Diabetes

 No

147(74.62)

50(25.38)

1.0195

0.313

 Yes

129(79.14)

34(20.86)

  

CKD

 No

262(75.72)

84(24.28)

 

0.047c

 Yes

14(100.00)

0(0.00)

  

Dyslipidaemia

 No

225(74.01)

79(25.99)

7.6921

0.006

 Yes

51(91.07)

5(8.93)

  

Stroke

 No

262(76.83)

79(23.17)

0.0997

0.752

 Yes

14(73.68)

5(26.32)

  

Pills taken for comorbidity

 1–2

84(80.77)

20(19.23)

 

0.725c

 3–6

130(83.87)

25(16.13)

  

7–13

3(75.00)

1(25.00)

  

Non-Prescribed Medb.

 No

209(76.56)

64(23.44)

0.0076

0.930

 Yes

67(77.67)

20(22.99)

  

Length of diagnosis

 1

21(63.64)

12(36.36)

11.9293

0.008

 2–5

112(84.21)

21(15.36)

  

 6–10

91(78.45)

25(21.55)

  

 21–40

52(66.67)

26(33.33)

  

No. BP pills taken per day

 1–2

85(64.89)

46(35.11)

15.978

< 0.001

 2–4

191(83.41)

38(16.59)

  

Total

276 (76.67)

84 (23.33)

  
  1. n: Frequencies,%:row percentages
  2. a Co-morbidity was defined as the presence of diabetes, chronic kidney disease or dyslipidaemia
  3. bNon-prescribed medication refers to any drug the patient is currently taking that is not prescribed by the attending physician
  4. c Fishers’ exact value